The chronic inflammation induced by human immunodeficiency virus (HIV) contributes to
increased risk of coronary heart disease (CHD) in HIV-infected individuals. HIV-infected …

Background: Noncommunicable diseases are common among chronically infected patients
with HIV in the developed world, but little is known about these conditions in African cohorts …

Introduction: cardiovascular risk factors are prevalent in HIV-positive patients which places
them at increased risk for cardiovascular disease (CVD). We aimed to determine the risk …

Background While dyslipidemia importantly contributes to increased cardiovascular disease
risk among patients on antiretroviral therapy (ART), data on lipid patterns among African …

Background The increased immune activation and inflammation of chronic HIV-infection and
the characteristic dyslipidemias associated with HIV infection and antiretroviral therapy …

Background With the introduction of effective antiretroviral therapy (ART), people living with
HIV (PLWH) are surviving longer and are at risk for developing metabolic abnormalities that …

Background Traditional cardiovascular disease (CVD) risk factors contribute to increase risk
of CVD in people living with HIV (PLWH). Of all world regions, sub-Saharan Africa has the …

Background HIV and combination antiretroviral therapy (cART) may increase cardiovascular
disease (CVD) risk. We assessed the early effects of cART on CVD risk markers in a …

Background: Highly active antiretroviral therapy (HAART) has become more accessible to
Human immunodeficiency virus infection/Acquired Immunodeficiency Syndrome (HIV/AIDS) …

Background Life expectancies of HIV-positive patients have been increasing with the rapid
implementation of antiretroviral therapy (ART). This has led to an increase in comorbidities …